COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination https://t.co/gl92AEr4xw https://t.co/9gnyghjO2C https://t.co/Gf53xuH4I6
Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2022 – Sep 2025Where it's discussed
-
X / Twitter83 posts
-
News3 articles
-
YouTube2 videos
-
Facebook2 posts
-
Blogs2 articles
AI synopsis
What people are saying
Within the discussions, several users highlight key statistics from the study, such as the 65% incidence rate of axillary lymphadenopathy among participants. Phrases like 'frequent' and questions about 'standard imaging guidelines' reflect a serious consideration of how this data affects clinical practice. The tone is generally informative, with some users expressing concern about the implications for cancer detection, deepening the overall engagement with the topic.
Many discussions generally align with the study's findings, acknowledging the prevalence of axillary lymphadenopathy following vaccination.
Users show considerable interest in the topic, especially given its implications for cancer imaging.
While several posts engage with the methods and findings of the study, some responses are more informational than deeply analytical.
The publication is perceived to have a significant impact on understanding vaccination side effects and imaging practices.
Abstract in brief
- The study investigates axillary lymphadenopathy (swelling of lymph nodes in the armpit) following COVID-19 vaccinations (Pfizer-BioNTech and Moderna), highlighting its significance in cancer imaging and the need for updated imaging guidelines.
- Out of 433 participants, 65% showed lymphadenopathy post-vaccination, with younger participants and those receiving the Moderna vaccine being more likely to experience this side effect.
- MRI scans revealed that enlarged lymph nodes had higher signal intensities and specific measurements were noted, indicating a noticeable change compared to pre-vaccination scans, which is crucial for differentiating vaccine effects from potential malignancies.
Top posts
Most liked on X and BlueskyAdénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs signalé des sénolologues sur #mammographies Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation https://t.co/APvdn9QuZm
Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopathy 1–14 days after vaccination was present in 65%. https://t.co/qjNeAiP0xl https://t.co/BCGoVpfR3K
Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation - PMC https://t.co/r0iPWDNPni
#RADIOLOGY New: #COVID In individuals with mRNA COVID-19 vaccination, 1% had enlarged axillary nodes ≥ 10 mm on MRI. https://t.co/0qF0OUsETp @radiology_rsna https://t.co/aoZPIY6Bfz
Vaccine-related adenopathy occurred after 1–14 days and was present in 65% of 433 participants who received a second dose of mRNA vaccine and underwent chest MRI. https://t.co/fFWjTBVx7W #COVID19 https://t.co/N4kO7YDq7U
All mentions
Understanding Armpit Pain After COVID-19 Vaccination
After receiving a vaccine, many people experience soreness or dull ache in their armpit. This discomfort can arise from tiny injuries near the injection site and lymph node swelling. Higher instances are found in…
Impact of COVID Vaccine on Axillary Lymphadenopathy Detection
The study investigates axillary lymphadenopathy following COVID-19 vaccinations, emphasizing its importance in cancer imaging. Out of 433 participants, 65% exhibited lymphadenopathy, underscoring the need for updated…
RT @CartlandDavid: Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation - PMC https://t.co/r0iPW…
RT @CartlandDavid: Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation - PMC https://t.co/r0iPW…
RT @CartlandDavid: Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation - PMC https://t.co/r0iPW…
RT @CartlandDavid: Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation - PMC https://t.co/r0iPW…
Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation - PMC https://t.co/r0iPWDNPni
@neilDCFC @RegggieCyde @Caerlynydd @BBCNews https://t.co/Tyt4WCg2WK
https://t.co/DFonxAvZz7
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
RT @AdverseReports: Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopat…
Tra i 433 partecipanti con una seconda dose di vaccino #mRNA e risonanza magnetica del torace, la linfoadenopatia ascellare correlata alla vaccinazione 1-14 giorni dopo la vaccinazione era presente nel 65%. https://t.co/kFchOq6tO8 https://t.co/MbprZbGDoW
Among 433 participants with a second dose of an #mRNA vaccine and chest MRI, vaccination-related axillary lymphadenopathy 1–14 days after vaccination was present in 65%. https://t.co/qjNeAiP0xl https://t.co/BCGoVpfR3K
T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination https://t.co/ePjTY2W9yN Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation https://t.co/8MCiUty4Ej COVID‐19 vaccine associated cervical
Lymphadenopathy after COVID vaccine https://t.co/fKMswKjWdJ
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
RT @Laissonslespre1: Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs s…
Adénopathies axillaires après vaccination #Moderna et #Pfizer #Biontech #ARNm sur clichés IRM Ce qu’ont par ailleurs signalé des sénolologues sur #mammographies Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation https://t.co/APvdn9QuZm
Axillary lymphadenopathy with Covid vaccination : what you need to know https://t.co/Yx77pI5GR4
RT @LautesS: Biontech und Moderna mRNA Impfungen vergrößern lokoregionäre Lymphknoten in der Axilla! Einige von diesen Personen haben Lang…
Biontech und Moderna mRNA Impfungen vergrößern lokoregionäre Lymphknoten in der Axilla! Einige von diesen Personen haben Langzeitbeschwerden = wird aber nicht als Nebenwirkung der Immunisierung anerkannt! https://t.co/1IfFryuZzL
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
Takeharu Yoshikawa, Soichiro Miki, Takahiro Nakao, Saori Koshino, Naoto Hayashi, and Osamu Abe. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation. Radiology 2023 306:1, 270-278 doi: 10.1148/radiol.220814 https://t.co/QEObzmQ2mT https://t.co/HzBVU9wdZR
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
RT @carpe_diem0820: COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axilla…
COVID-19ワクチン接種後の腋窩リンパ腺腫脹 2週間以内では65% 3~4週間以内では40% 8週間以上は稀 モデルナ>ファイザー(40 vs 19%) 女性>男性(29 vs 17%) 殆どが1-2個のリンパ節種大 Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination https://t.co/gl92AEr4xw https://t.co/9gnyghjO2C https://t.co/Gf53xuH4I6
[Radiology] Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation - https://t.co/SMaebVqmc5 https://t.co/V0jr2Ft45M
@Truth1083520118 @ARCOCOMIC It has. Here is a study for you. It says it was actually quite frequent. https://t.co/oW7gglzkFw
(Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Analysis – RSNA Publications On-line) has been published on The Globe - https://t.co/b4E0yqYjXj
Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation | Radiology https://t.co/X2JwFW6qNI
RT @radiology_rsna: Vaccine-related adenopathy occurred after 1–14 days and was present in 65% of 433 participants who received a second do…
#RADIOLOGY New: #COVID In individuals with mRNA COVID-19 vaccination, 1% had enlarged axillary nodes ≥ 10 mm on MRI. https://t.co/0qF0OUsETp @radiology_rsna https://t.co/aoZPIY6Bfz
Vaccine-related adenopathy occurred after 1–14 days and was present in 65% of 433 participants who received a second dose of mRNA vaccine and underwent chest MRI. https://t.co/fFWjTBVx7W #COVID19 https://t.co/N4kO7YDq7U
Axillary lymphadenopathy after 2nd dose of Pfizer-BioNtech or Moderna COVID-19 vaccine frequent within 2 weeks, less than 10mm, normal ADC Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation https://t.co/PE3CxTE79w https://t.co/W5b6rupypT